4 completed, 1 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Terminated 1 |
Follow epelsiban: new trials by email Literature Review of epelsiban trials Research Report on epelsiban
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers Epelsiban (GSK557296), Placebo to match GSK557296 - Embryo Transfer | Phase 1 | Completed | GlaxoSmithKline | 31 | 2015-07-09 | 2018-09-13 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers Epelsiban - Embryo Transfer | Phase 1 | Completed | GlaxoSmithKline | 12 | 2014-12-18 | 2018-09-13 |
| A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban Epelsiban, Placebo, Oxytocin - Embryo Transfer | Phase 1 | Terminated | GlaxoSmithKline | 33 | 2014-08-28 | 2017-05-08 |
| Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing GSK557296 10 mg, GSK557296 150 mg, GSK557296 dose 3 - Embryo Transfer | Phase 1 | Completed | GlaxoSmithKline | 36 | 2012-08-16 | 2017-06-07 |
| A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296. GSK557296 - Obstetric Labour, Premature, Premature Ejaculation | Phase 1 | Completed | GlaxoSmithKline | 42 | 2007-10-01 | 2012-03-19 |
Premature Birth (1) · Premature Ejaculation (1)
GlaxoSmithKline (5)
United States (5)